The Executive Committee (EXCO) of the Medical and Dental Professions Board noted a concern brought to the Board on the off-label use of drugs on children with gender dysphoria.
The EXCO has issued an advisory to practitioners that the off-use label drugs needs to be done with care, consent and be based on scientific evidence. Practitioners are advised to adhere to the above-mentioned advisory .
Last Updated on 12 August 2024 by HPCSA Corporate Affairs